Obagi Medical Products Inc

Type: Company
Name: Obagi Medical Products Inc
Nationality: United States
Web Address: http://www.obagi.com/
First reported May 14 2013 - Updated May 14 2013 - 1 reports

Tyler Perry Accepts Humanitarian Award at ‘Shall We Dance’ Gala

Tyler Perry was the guest of honor over the weekend at the “Shall We Dance” gala, presented by the Coalition for at Risk Youth (CARRY).The director, alongside Janie Bradford, Laura Hunter and Dr. Jerome Porath, were presented with Orchid Humanitarian ... [Published Haute Living Magazine - May 14 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals ... [Published NewsRX - May 03 2013]
First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

Obagi Medical Products, Inc. (NASDAQ:OMPI) Investor Alert: Lawsuit to Halt Takeover Filed

mail@shareholdersfoundation.com - Apr. 30, 2013 - SAN DIEGO -- An investor in shares of Obagi Medical Products, Inc. (NASDAQ:OMPI) filed a lawsuit to halt the takeover of Obagi Medical Products, Inc. by Valeant Pharmaceuticals International at $19.75 ... [Published Prlog - Apr 30 2013]
First reported Apr 30 2013 - Updated Apr 30 2013 - 1 reports

62.9% Return Seen to Date on SmarTrend Obagi Medical Products Call (OMPI)

(Comtex SmarTrend(R)) SmarTrend identified an Uptrend for Obagi Medical Products (NASDAQ:OMPI) on March 15th, 2013 at $14.72. In approximately 2 months, Obagi Medical Products has returned 62.91% as of today's recent price of $23.98. Obagi Medical ... [Published Individual.com - Apr 30 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Form 4 Obagi Medical Products, For: Apr 25 Filed by: Bartholdson John A.

StreetInsider.com - Form 4 Obagi Medical Products, For: Apr 25 Filed by: Bartholdson John A. ... [Published Street Insider - Apr 29 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Form 4 Obagi Medical Products, For: Apr 25 Filed by: Taylor Mark Thomas

StreetInsider.com - Form 4 Obagi Medical Products, For: Apr 25 Filed by: Taylor Mark Thomas ... [Published Street Insider - Apr 29 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 2 reports

Form 4 Obagi Medical Products, For: Apr 25 Filed by: Hunter Laura B.

StreetInsider.com - Form 4 Obagi Medical Products, For: Apr 25 Filed by: Hunter Laura B. ... [Published Street Insider - Apr 29 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Form 4 Obagi Medical Products, For: Apr 25 Filed by: Romm Preston S

StreetInsider.com - Form 4 Obagi Medical Products, For: Apr 25 Filed by: Romm Preston S ... [Published Street Insider - Apr 29 2013]
First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

Form 8-K Obagi Medical Products, For: Apr 25

StreetInsider.com - Form 8-K Obagi Medical Products, For: Apr 25 ... [Published Street Insider - Apr 26 2013]
First reported Apr 25 2013 - Updated Apr 25 2013 - 3 reports

Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.

LAVAL, QuebecThe Offer expired at midnight, New York City ... [Published Bio-Medicine - Apr 25 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

63.0% Return Seen to Date on SmarTrend Obagi Medical Products Call (OMPI)

(Comtex SmarTrend(R)) SmarTrend identified an Uptrend for Obagi Medical Products (NASDAQ:OMPI) on March 15th, 2013 at $14.72. In approximately 1 month, Obagi Medical Products has returned 62.98% as of today's recent price of $23.99. Obagi Medical P ... [Published Individual.com - Apr 23 2013]
First reported Apr 22 2013 - Updated Apr 23 2013 - 3 reports

Valeant Pharmaceuticals clears regulatory hurdle in Obagi takeover deal

MONTREAL - Valeant Pharmaceuticals International Inc. (TSX:VRX) said Monday it has cleared a U.S. regulatory hurdle in its deal to buy Obagi Medical Products Inc.The drug company said the expiration of the waiting period under the Hart-Scott-Rodino Antitrust ... [Published Brandon Sun - Apr 22 2013]

Quotes

...1 billion in fully diluted equity value, for the company. Oracle announced the deal on Feb. 4. Acme Packet said the merger would "accelerate the migration to all-IP networks by enabling secure and reliable communications from any device, across any network" and their board unanimously approved the transaction. Shares shot from $23...
...Customer retention and upselling were key factors in earnings growth. This had exceeded the company's own expectations: "On the heels of Q4's record sales performance, our team had the best first quarter in history;" all good signs for the quarters ahead. As a finishing touch, cash holdings also increased by $12 million to $124 million in total...
In any case, Valeant isn't the kind of company to wait, said Kedra. "When they see something they want, they go for it and they usually act quickly ... or they walk away quickly" he said

More Content

All (184) | News (92) | Reports (4) | Blogs (21) | Audio/Video (0) | Fact Sheets (0) | Press Releases (67)
sort by: Date | Relevance
Tyler Perry Accepts Humanitarian Award at ‘Shal... [Published Haute Living Magazine - May 14 2013]
Mario Gabelli Surges to Record $40B AUM - Dell,... [Published Nasdaq - May 11 2013]
Valeant Pharmaceuticals: Don't Take Profits Yet... [Published Seeking Alpha - May 10 2013]
Tyler Perry To Be Honored At CARRY's Shall We D... [Published Look to the Stars - May 10 2013]
Sell in May, But Don't Go Away [Published Motley Fool - May 08 2013]
Valeant Beats Earnings, Misses Revs Zacks [Published Yahoo! Finance - May 03 2013]
Valeant Pharmaceuticals International, Inc. Com... [Published NewsRX - May 03 2013]
Deal maker Valeant reaches for biggest prize yet [Published 92.9 WLMI - Apr 30 2013]
Deal maker Valeant reaches for biggest prize yet [Published 1440 WNFL - Apr 30 2013]
Obagi Medical Products, Inc. (NASDAQ:OMPI) Inve... [Published Prlog - Apr 30 2013]
62.9% Return Seen to Date on SmarTrend Obagi Me... [Published Individual.com - Apr 30 2013]
Rumoured Valeant merger with Actavis stalls [Published PMLive - Apr 30 2013]
Business briefs: Merck and Pfizer; Valeant and ... [Published Medical Marketing And Media - Apr 30 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Form 4 Obagi Medical Products, For: Apr 25 File... [Published Street Insider - Apr 29 2013]
Valeant bid to buy Actavis rumoured to have sta... [Published Pharma Times - Apr 29 2013]
UPDATE 1-Merger of drugmakers Valeant, Actavis ... [Published Reuters UK - Apr 28 2013]
Valeant Said to Be in Merger Talks With Rival A... [Published Washington Post - Apr 27 2013]
Valeant in Talks With Actavis on Merger of Gene... [Published Bloomberg - Apr 27 2013]
Qihoo, Grifols Shape New Price Patterns [Published Investors Business Daily - Apr 26 2013]
Form 8-K Obagi Medical Products, For: Apr 25 [Published Street Insider - Apr 26 2013]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
4 Healthcare Stock Stories Prescribed for Inves... [Published Wall St. Cheat Sheet - Apr 24 2013]
AstraZeneca Group ( NYSE:AZN ): Closing price $51.94 BIND Therapeutics and AstraZeneca announced that they will work jointly to develop and commercialize an Accuri, which is a targeted and programmable cancer nanomedicine from BIND’s Medicinal Nanoengineering ...
Monday Deal Review: April 22, 2013 [Published The Cross-Border Biotech Blog - Apr 22 2013]
Welcome to your Monday Biotech Deal Review for April 22, 2013! Aeterna Zentaris has had a busy two weeks on the commercial front, signing agreements with Merck and Ergomed.  However, there was a lot more action as well.  Hit the break to catch up on ...
Stocks to Watch: Lufkin, Obagi, Constellation B... [Published WSJ.com: MarketBeat - Apr 08 2013]
Among the companies with shares expected to actively trade in Monday's session are Lufkin Industries, Obagi Medical Products and Constellation Brands. ...
36 Stocks Making Big M&A News and Rumors This Week [Published Wall St. Cheat Sheet - Apr 07 2013]
Here’s your Cheat Sheet to this week’s top mergers and acquisition news: Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now ! Amazon.com ( NASDAQ:AMZN ): Current price $255.38 All Things ...
Obagi Subject of Bidding War and 2 Stocks at 52... [Published Wall St. Cheat Sheet - Apr 05 2013]
Adobe Systems Incorporated ( NASDAQ:ADBE ): Closing price $44.21 On Thursday, the company announced Adobe Anywhere for video, a modern, collaborative workflow platform that allows teams using Adobe professional video tools to collaborate, enabling ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Valeant Pharmaceuticals International, Inc. Com... [Published PR Newswire: Health - Apr 25 2013]
Valeant Pharmaceuticals International, Inc. Ann... [Published PR Newswire: Financial Services - Apr 24 2013]
Valeant Pharmaceuticals Announces Extension of ... [Published PR Newswire: Health - Apr 23 2013]
Valeant Pharmaceuticals Announces Receipt Of An... [Published PR Newswire: Financial Services - Apr 22 2013]
The Zacks Analyst Blog Highlights: Safeway, Val... [Published Financial Services - Apr 10 2013]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.